Cargando…
Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities
Tuberculosis (TB) is one of the communicable diseases caused by Mycobacterium tuberculosis (Mtb) infection, affecting nearly one-third of the world’s population. However, because the pathogenesis of TB is still not fully understood and the development of anti-TB drug is slow, TB remains a global pub...
Autores principales: | Zhang, Xueying, Xie, Qi, Ye, Ziyu, Li, Yanyun, Che, Zhengping, Huang, Mingyuan, Zeng, Jincheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340780/ https://www.ncbi.nlm.nih.gov/pubmed/34367155 http://dx.doi.org/10.3389/fimmu.2021.695278 |
Ejemplares similares
-
Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
por: Che, Zhengping, et al.
Publicado: (2022) -
Gingiva-Derived Mesenchymal Stem Cells Attenuate Imiquimod- (IMQ-) Induced Murine Psoriasis-Like Skin Inflammation
por: Ye, Ziyu, et al.
Publicado: (2022) -
An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases
por: Li, Yanyun, et al.
Publicado: (2021) -
T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023) -
Beta-1 syntrophin (SNTB1) regulates colorectal cancer progression and stemness via regulation of the Wnt/β-catenin signaling pathway
por: Liang, Yanfang, et al.
Publicado: (2021)